New Study- What If You Could Drink Your Sleep Aid?

January 27, 2011

Did you know twenty million people experience occasional sleep problems each year?

The Atlanta Sleep Medicine Clinic recently posted on Healthy People 2020 & the government’s decision to include sleep health in their report on national health objectives and goals. As sleep health awareness continues to grow, many people are beginning to seek medical help in dealing with their sleep problems.

You may be familiar with CPAP therapy for sleep apnea patients as well as the variety of medications available for insomnia or narcolepsy. But what if, instead of taking a pill, you could drink your sleep aid?

NeuroTrials Research is currently conducting a clinical research study to evaluate the effectiveness of a sleep drink for those with poor sleep quality. The study requires only 3 in-office visits and qualified participants may be compensated for time and travel.

If you are generally a good sleeper but have been experiencing unsatisfactory sleep for 2-3 nights throughout the past month you may qualify to participate in this study. Participants must be between 25-65 years of age and cannot work a night shift.

For more information on this study, call 404-851-9934 or visit NeuroTrials.


Dr. Lacey’s Appearance on “In Session”

January 12, 2011

Did you catch Atlanta Sleep Medicine Clinic Co-Founder and Medical Director and primary investigator at NeuroTrials Research,  Dr. Michael Lacey will appear on CNN Justice’s In Session this Monday?

If not, or to participate in the discussion sparked by the video, view the video and discussion.

During his appearance, Dr. Lacey discussed a variety of medications and their relation to insomnia, as well as other sleep disorder treatment options.

Dr. Lacey is board certified in sleep medicine and neurology and trained at Eastern Virginia Medical School and Eastern Virginia Graduate School of Medicine. He later completed a fellowship in Epilepsy/Neuromuscular Disease at Emory University. In addition to his work as ASMC Medical Director and primary investigator with NeuroTrials, Dr. Lacey is a frequent lecturer at the Atlanta School of Sleep Medicine and acts as primary investigator for sleep and neurology clinical trials conducted by NeuroTrials Research.

If you suffer from insomnia or sleep apnea, you may qualify to participate in a research study. Visit our Website for information about current studies.


Dr. Lacey To Appear Live on CNN’s “In Session”

January 7, 2011

Atlanta Sleep Medicine Clinic Co-Founder and Medical Director and primary investigator at NeuroTrials Research,  Dr. Michael Lacey will appear live on CNN Justice’s In Session this Monday, January 10 at 11 AM.

insession

Discussing the Conrad Murray case with host Ryan Smith, Dr. Lacey will be speaking about the correct way to treat individuals with sleeping disorders and the possible side effects from treatment.

In Session uses a diverse team of legal experts to provide analysis and opinion on the nation’s most compelling cases. The show airs Monday-Friday from 9am-3pm on truTV.

Dr. Lacey is board certified in sleep medicine and neurology and trained at Eastern Virginia Medical School and Eastern Virginia Graduate School of Medicine. He later completed a fellowship in Epilepsy/Neuromuscular Disease at Emory University. In addition to his work as ASMC Medical Director, Dr. Lacey is a frequent lecturer at the Atlanta School of Sleep Medicine.


Epilepsy Develops in 1 in 26 Over Lifetime

January 4, 2011
epilepsy

1 in 26 will develop epilepsy

According to a new study published in the January 4 edition of Neurology, at least one in 26 people will develop epilepsy in their lifetime.

Researchers analyzed data from 412 people diagnosed with epilepsy between 1960 and 1979. The study also found that the risk of epilepsy increases with age, with a 1.6% risk for those under age 50 and a 3% risk for ages 51-80. 

Study results suggest that up to 12 million Americans will develop epilepsy, a neurological disorder characterized by repeated, spontaneous seizures. A greater number than originally anticipated, researchers also pointed out that even this estimate could be conservative, since the risk of epilepsy would be greater in highly populated urban areas.

The study also found that men were more likely to develop epilepsy than women (1 in 21 versus 1 in 28).

There are over 40 different types of epilepsy, and each is characterized by its own unqiue combination of seizure type, age of onset, EEG findings, and treatment options. 200,000 new cases of epilepsy are diagnosed each year and in 70% of new cases, no cause is apparent.

If you or someone you know has been diagnosed with epilepsy, and live near the Atlanta area, consider participating in NeuroTrials Research’s clinical research study. We are currently evaulating an investigational drug for epilepsy to be used as an add-on to current medication. You may be eligible to participate if you are 17 years or older, have been diagnosed with epilepsy, and have been taking medication for your seizures. For more information visit our studies page or call us at (404) 851-9934.